List view / Grid view

News

Bristol-Myers Squibb and Samsung BioLogics expand manufacturing agreement

23 April 2014 | By Bristol-Myers Squibb Company

Bristol-Myers Squibb Company and Samsung BioLogics announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site...

EMA and Australian regulator strengthen collaboration in the area of orphan medicines

7 April 2014 | By The European Medicines Agency

In a meeting at the European Medicines Agency on 4 April 2014, the EMA’s Executive Director, Prof. Guido Rasi, and the National Manager of the Australian Therapeutic Goods AdministrationExternal link icon, Prof. John Skerritt, announced that the two regulators have agreed to share the full assessment reports...